-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Vanda Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2010 to 2023.
- Vanda Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.08 USD/shares, a 367% decline year-over-year.
- Vanda Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.2 USD/shares, a 177% decline year-over-year.
- Vanda Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was 0.04 USD/shares, a 63.6% decline from 2022.
- Vanda Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2022 was 0.11 USD/shares, a 81.7% decline from 2021.
- Vanda Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2021 was 0.6 USD/shares, a 39.5% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)